Barclays PLC Pardes Biosciences, Inc. Transaction History

Barclays PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$0.0 - $2.16 $0 - $809,529	-374,782 Reduced 92.35%	31,037 $67,000
Q2 2023 Aug 03, 2023	BUY	$1.4 - $1.95 $543,537 - $757,069	388,241 Added 2208.68%	405,819 $735,000
Q1 2023 May 04, 2023	BUY	$1.21 - $2.22 $10,114 - $18,556	8,359 Added 90.67%	17,578 $23,000
Q4 2022 Feb 13, 2023	BUY	$0.85 - $1.69 $6,123 - $12,174	7,204 Added 357.52%	9,219 $15,000
Q3 2022 Nov 03, 2022	SELL	$2.14 - $3.7 $84,611 - $146,290	-39,538 Reduced 95.15%	2,015 $4,000

Q2 2022 Aug 12, 2022	SELL	$2.84 - $8.57 $3,541 - $10,686	-1,247 Reduced 2.91%	41,553 $127,000
Q1 2022 May 16, 2022	BUY	$5.64 - $15.64 $241,392 - $669,392	42,800 New	42,800 $309,000

5.23M

Ticker PRDS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,320,900
Description
Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome ...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.